4Gnff DC,Posever T,et al.An exploratory Haloperidol Controlled do se finding study of ziprasidone inhospital-ized patients with Schizophrenia or Schizoaffective disored[].Journal of Clinical Psychopharmacology.2000
二级参考文献67
1[1]Baldessarini RJ,Tarazi FI.Drugs and the treatment of psychiatric disorders:Antipsychotic and antimanic agents.In:Hardman JG,Limbird LE,Gilman AG,editors.Goodman and Gilman's the pharmacological basis of therapeutics[M].10th ed.New York:McGraw-Hill Press;2001:485.
2[2]Tuunainen A,Wahlbeck K,Gilbody SM.Newer atypical antipsychotic medication versus clozapine for schizophrenia[J].Cochrane Database Syst Rev,2000,(2):CD000966.
3[3]Addington DE,Pantelis C,Dineen M,et al.Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder:an 8-week,double-blind,multicenter trial[J].J Clin Psychiatry,2004,65:1624.
5[5]Moller HJ.Management of the negative symptoms of schizophrenia:new treatment options[J].CNS Drugs,2003,17:793.
6[6]Coe R.What is an effect size:a guide for users.Durham(UK):Evidence-Based Education UK[EB/OL].Available:www.cemcentre.org/ebeuk/research/effectsize/ESguide.htm(accessed 2005 5 19).
7[7]Bilder RM,Goldman RS,Volavka J,et al.Neurocognitive effects of clozapine,olanzapine,risperidone,and haloperidol in patients with chronic schizophrenia or schizoaffective disorder[J].Am J Psychiatry,2002,159:1018.
8[8]Keefe RS,Seidman LJ,Christensen BK,et al.Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis:a randomized,double-blind trial of olanzapine versus low doses of haloperidol[J].Am J Psychiatry,2004,161:985.
9[9]Csernansky JG,Mahmoud R,Brenner R.The Risperidone-USA-79 Study Group.A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia[J].N Engl J Med,2002,346:16.
10[10]Schooler N,Rabinowitz J,Davidson M,et al.Early Psychosis Global Working Group.Risperidone and haloperidol in first-episode psychosis:a long-term randomized trial[J].Am J Psychiatry,2005,162:947.
1Gof 13(3, Posever T,Herz L, et al. An exploratory haloperidol controlled dosefinding study of zip in hospitalized patientswithschizophreniaor schizoaffec-tire disorder [J]. J Clin Psychopharmaeol, 1998,18(4) : 296-304.
2Keek P,Bufenstein A,Ferguson J,et al. The zip study group:zip 40 and 1 20 mg/d in the acute exacerbation of schizophrenia and schizoaffective disorder:A4 week placebo controlled trial[J]. Psye-hopharmacology, 1998,140 (2) : 173-184.
3Harvey PD, Bowie CR. Ziprasidone.. efficacy, tolerability, and e- menging data on wide--ranging effectivness[J],Expert Opin Pharmacother, 2005,6 : 337.
